Category Archives: People

FEATOL Rolls Out Reinforced Lower Back Brace to Help Adults During Work, Driving, and in Chronic Pain

The latest adjustable lumbar support from FEATOL combines stability with comfort, providing much-needed mobility support for those experiencing lower back fatigue NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — With more adults engaged in manual labor, long-distance driving, and chronic back pain, FEATOL has unveiled a supportive lower back brace. Rather than a temporary recovery […]

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Data Demonstrate Vamorolone’s Balanced Corticosteroid Profile with On-Target Glucocorticoid Activity and Without Evidence of Significant Immunosuppressive Activity at Clinical Doses CORAL GABLES, Fla., June 30, 2026 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, […]

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Succeeds Co-Founder Corey Goodman, Ph.D., After More Than a Decade of Foundational Leadership SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to […]

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) — Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced the formation of a Scientific Advisory Board (SAB) of leading clinicians to support the advancement of LAM-001, an inhaled formulation […]

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program. NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that Weight Watchers Med+ will support Medicare members seeking access to GLP-1 medications under […]

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

ZORYVE cream 0.3% is the first once-daily, non-steroidal therapy approved for children with plaque psoriasis as young as 2 years of age ZORYVE cream 0.3% is safe, effective, and well-tolerated for use anywhere on the body with no restrictions on duration of use Seventh FDA approval for ZORYVE in four years WESTLAKE VILLAGE, Calif., June […]

Twentyeight Health partners with Clue to expand access to affordable birth control nationwide

Bridging the gap between daily cycle tracking and provider-led contraceptive care for personalized reproductive health NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) — Twentyeight Health, the leading women’s telehealth platform, today announced a partnership with Clue, the science-backed menstrual and reproductive health app trusted by millions worldwide. Through this partnership, US-based Clue users can seamlessly access […]

PetVivo Reports Financial and Operational Results for Fiscal 2026

MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported operational results for the fourth quarter of its […]

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Board-certified ophthalmologist and ASOPRS fellowship-trained surgeon Dr. Christopher I. Zoumalan, MD, FACS, explains how his trademarked Natural Looking Blepharoplasty® reflects the 2026 “less-is-more” movement in facial aesthetics. Beverly Hills, CA, June 29, 2026 (GLOBE NEWSWIRE) — Zoumalan, MD FACS Inc. today announced its trademarked Natural Looking Blepharoplasty® approach to eyelid rejuvenation as growing demand for […]

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada NEW YORK and TORONTO, June 29, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) (“Tilray”), a global leader in medical cannabis, today announced the acquisition of HelloMD Corporation, a digital […]